YiChang HEC ChangJiang Pharmaceutical Co., Ltd.

宜 昌 東 陽 光 長 江 藥 業 股 份 有 限 公 司

(A joint stock company incorporated in the People's Republic of China with limited liability)

(Stock Code: 01558)

Form of Proxy for the Annual General Meeting to be held on 4 June 2021

(or any adjournment thereof)

Number of Shares Related

Domestic Shares

to this Form of Proxy (Note 1)

H Shares

I/We (Note 2)

of (address)

being the registered holder(s) of

domestic/H shares (Note 3)

of RMB1.00 each in the share capital of YiChang HEC ChangJiang Pharmaceutical Co., Ltd. (the ''Company'') hereby appoint the Chairman of the meeting or

(Note 4)

of (address)

as my/our proxy to attend and vote for me/us and on my/our behalf at the annual general meeting of the Company (the ''AGM'') to be held at Conference Room, 4/F, Administration Building, Dongyangguang Scientific Park, No. 368 Zhen An Zhong Road, Chang'an County, Dongguan, Guangdong Province, the People's Republic of China (the ''PRC''), at 10:00 a.m. on Friday, 4 June 2021 (or at any adjournment thereof) in respect of the resolutions as set out in the notice of AGM dated 16 April 2021 as hereunder indicated and, if no such indication is given, as my/our proxy thinks fit.

ORDINARY RESOLUTIONS

For (Note 5)

Against (Note 5)

Abstain (Note 5)

1. To review and approve the report of the Board of Directors for the year ended 31 December 2020.

2. To review and approve the report of the Board of Supervisors for the year ended 31 December 2020.

3. To review and approve the consolidated financial statements of the Company for the year ended 31 December 2020.

4. To review and approve the 2020 annual report of the Company.

  1. To review and approve the re-appointment of KPMG as auditor of the Company for a term until the conclusion of the next annual general meeting of the Company, and authorize the Board of Directors to determine its remuneration.
  2. To review and approve the election of Mr. Jiang Juncai as an executive director for the third session of the Board of Directors.
  3. To review and approve the election of Mr. Wang Danjin as an executive director for the third session of the Board of Directors.
  4. To review and approve the election of Mr. Chen Yangui as an executive director for the third session of the Board of Directors.
  5. To review and approve the election of Mr. Li Shuang as an executive director for the third session of the Board of Directors.
  6. To review and approve the election of Mr. Tang Xinfa as a non-executive director for the third session of the Board of Directors.
  7. To review and approve the election of Mr. Eddy Huang as a non-executive director for the third session of the Board of Directors.
  8. To review and approve the election of Mr. Tang Jianxin as an independent non-executive director for the third session of the Board of Directors.
  9. To review and approve the election of Mr. Zhao Dayao as an independent non-executive director for the third session of the Board of Directors.
  10. To review and approve the election of Ms. Xiang Ling as an independent non-executive director for the third session of the Board of Directors.
  11. To review and approve the election of Mr. Li Xuechen as an independent non-executive director for the third session of the Board of Directors.
  12. To review and approve the election of Mr. Tang Jinlong as a shareholder representative supervisor for the third session of the Board of Supervisors.
  13. To review and approve the election of Mr. Luo Zhonghua as a shareholder representative supervisor for the third session of the Board of Supervisors.

SPECIAL RESOLUTIONS

For (Note 5)

Against (Note 5)

Abstain (Note 5)

18. To consider and approve the general mandates to the Board to issue Shares.

19. To consider and approve the general mandates to the Board to repurchase H Shares.

Date:

Signature (Note 6):

Notes:

  1. Please insert the number of shares of the Company registered in your name(s) to which this form of proxy relates. If a number is inserted, this form of proxy will be deemed to relate only to those shares. If no number is inserted, the form of proxy will be deemed to relate to all shares of the Company registered in your name(s) (whether alone or jointly with others).
  2. Please insert the full name(s) and address(es) as registered in the register of members of the Company in BLOCK LETTERS.
  3. Please insert the number of shares of the Company registered in your name(s) and delete as appropriate.
  4. If any proxy other than the Chairman of the meeting of the Company is preferred, please strike out the words ''the Chairman of the meeting or'' and insert the name of the proxy desired in the space provided. A shareholder may appoint one or more proxies to attend and vote on his/her behalf. A proxy need not be a shareholder of the Company. Any alteration made to this form of proxy must be initialed by the person who signs it.
  5. Important: If you wish to vote for any resolution, please put a tick in the box marked ''FOR'' or insert the number of shares held by you. If you wish to vote against any resolution, please put a tick in the box marked ''AGAINST'' or insert the number of shares held by you. If you want to abstain from voting on any resolution, please put a tick in the box marked ''ABSTAIN'' or insert the number of shares held by you. If no direction is given, your proxy may vote as he/she thinks fit. The shares abstained will be counted in the calculation of the required majority.
  6. This form of proxy must be signed by you or your attorney duly authorized in writing or, in the case of a corporation, must be either executed under its common seal or under the hand of its director or attorney or other officer duly authorized. In case of joint holders, this form of proxy may be signed by any of such joint holders.
  7. To be valid, this form of proxy and, if such proxy is signed by a person on behalf of the appointer pursuant to a power of attorney or other authority, a notarized copy of that power of attorney or other authority must be delivered, for holders of domestic shares, to the Company's Board office at Securities Department, Dongyangguang Scientific Park, No. 368 Zhen An Zhong Road, Chang'an County, Dongguan, Guangdong Province, the PRC, or for holders of H shares, to the Company's H share registrar in Hong Kong, Computershare Hong Kong Investor Services Limited at 17M Floor, Hopewell Centre, 183 Queen's Road East, Wanchai, Hong Kong not less than 24 hours before the time for holding of the AGM or any adjournment thereof (i.e. before 10:00 a.m. on Thursday, 3 June 2021).
  8. Where there are joint holders of any share of the Company, any one of such persons may vote at the AGM, either personally or by proxy, in respect of such share as if he or she was solely entitled thereto, but if more than one of such joint holders are present at the AGM, personally or by proxy, that one of the said persons so present whose name stands first on the register in respect of such share shall alone be entitled to vote in respect thereof. The vote of the senior joint shareholder who tenders a vote, whether in person or by proxy, will be accepted to the exclusion of the votes of the other joint shareholder(s) and for this purpose, seniority will be determined by the order in which the names stand in the register of members of the Company in respect of the joint shareholding of such shares.
  9. Please be advised that completion and delivery of this form of proxy will not preclude you from attending and voting at the AGM or any of its adjournments in person should you so wish.
  10. Unless otherwise defined, capitalized terms used in this form of proxy shall have the same meaning as those defined in the circular dated 16 April 2021 of the Company.

Attachments

  • Original document
  • Permalink

Disclaimer

Yichang Hec Changjiang Pharmaceutical Co. Ltd. published this content on 15 April 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 15 April 2021 09:20:09 UTC.